|
시장보고서
상품코드
2050505
유전자 편집 시장 : 제품별, 기술별, 용도별, 최종사용자별, 지역별Gene Editing Market, By Product, By Technology, By Application, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
유전자 편집 시장은 2026년에 53억 달러로 추정되고 있으며, 2033년까지 105억 9,000만 달러에 달할 것으로 전망되고 있습니다. 2026-2033년에는 CAGR 10.4%로 성장할 것으로 예측됩니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 53억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 10.40% | 2033년 금액 예측 : | 105억 9,000만 달러 |
유전자 편집은 생물의 DNA에 표적화된 변화를 줄 수 있는 유전공학의 일종입니다. 이 기술은 치료 목적의 변형 및 형질개량을 위한 비용 효율적인 옵션을 제공함으로써 유전자 편집의 적용 범위와 효율성을 크게 확대했습니다. 글로벌 유전자 편집 시장은 다양한 연구, 치료 및 농업 응용 분야에서 게놈 유전자 편집과 관련된 툴, 제품 및 서비스를 포함합니다. 지난 10년간 유전자 편집은 질병 치료와 농업 분야에서 큰 잠재력을 가진 프론티어 기술로 자리 잡았습니다. 정확성, 안전성 및 도입 방법의 지속적인 개선으로 기존 산업에 혁신을 가져오고 현대 생명공학을 변화시킬 것으로 기대됩니다.
시장 역학
세계의 유전자 편집 시장은 민간 및 공공 자금의 바이오기술 연구개발 투자 확대에 힘입어 성장하고 있습니다. CRISPR-Cas9 및 기타 유전자 편집 툴의 발전으로 치료적 응용 가능성이 확대되어 시장 성장을 촉진하고 있습니다. 또한 시퀀싱 및 합성 비용의 감소로 인해 유전자 편집 기술에 대한 접근성이 향상되고 있습니다. 그러나 유전자 편집 작물 및 치료용 제품의 상용화를 둘러싼 규제적 우려는 여전히 시장 성장을 저해하고 있습니다. 또한 확립된 전달 방법의 부재와 오프 타겟 편집도 여전히 큰 문제점으로 남아있습니다. 생체내 전달 시스템의 개발은 새로운 질병 치료 분야로 확장할 수 있는 기회를 제공합니다. 농업 분야에서의 상업적 응용이 성공하면 장기적으로 유망한 전망이 열릴 것입니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 매출기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요 인사이트를 제공합니다.
- 이 연구는 다음과 같은 매개 변수를 기반으로 세계의 유전자 편집 시장의 주요 기업 개요을 작성했습니다. 구체적으로는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 세계의 유전자 편집 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 글로벌 유전자 편집 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 유전자 편집 시장 : 제품별, 2021-2033년
제5장 세계의 유전자 편집 시장 : 기술별, 2021-2033년
제6장 세계의 유전자 편집 시장 : 용도별, 2021-2033년
제7장 세계의 유전자 편집 시장 : 최종사용자별, 2021-2033년
제8장 세계의 유전자 편집 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 애널리스트의 제안
제11장 참고 문헌 및 조사 방법
KSA 26.06.10Gene Editing Market is estimated to be valued at USD 5.30 Bn in 2026 and is expected to reach USD 10.59 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 5.30 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 10.40% | 2033 Value Projection: | USD 10.59 Bn |
Gene editing is a type of genetic engineering which allows targeted changes to be made to an organism's DNA. Technologies, have greatly expanded the scope and efficiency of gene editing by providing cost-effective options for therapeutic modifications and trait improvements. The global gene editing market encompasses tools, products, and services related to gene editing of genomes in various research, therapeutic, and agricultural applications. Over the past decade, gene editing has become a frontier technology with significant potential for disease treatment and agriculture. With continued improvements in precision, safety, and delivery methods, is anticipated to disrupt established industries and transform modern biotechnology.
Market Dynamics
The global gene editing market is driven by growing investments in biotechnology research and development from both private and public sources. Advancements in CRISPR-Cas9 and other gene editing tools have expanded the potential for therapeutic applications, boosting market growth. Reduced costs of sequencing and synthesis are also improving access to gene editing technologies. However, regulatory concerns around the commercialization of gene edited crops and therapeutic products continue to restrain market growth. Additionally, lack of established delivery methods and off-target editing remain major challenges. The development of in vivo delivery systems presents an opportunity for expansion into new disease treatment areas. Successful commercial applications in agriculture also present a promising prospect over the long term.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global gene editing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include CRISPR Therapeutics, Editas Medicine, Intellia Therapeutics, Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Horizon Discovery, Sangamo Therapeutics, Cellectis, Genomatix, Integrated DNA Technologies, New England Biolabs, Takara Bio, Bio-Rad Laboratories, and Ginkgo Bioworks
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global gene editing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gene editing market
Market Segmentation
- Product Insights (Revenue, USD Bn, 2026 - 2033)
- Kits
- Reagents
- Software
- Technology Insights (Revenue, USD Bn, 2026 - 2033)
- Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
- Transcription Activator-Like Effector Nuclease (TALEN)
- ZFN (Zinc Finger Nucleases)
- Meganucleases
- Prime Editing
- Others (PiggyBac, etc.)
- Application Insights (Revenue, USD Bn, 2026 - 2033)
- Cell Line Engineering
- Genetic Engineering
- Drug Discovery
- Clinical Diagnostics
- Xenotransplantation
- Agriculture
- End User Insights (Revenue, USD Bn, 2026 - 2033)
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations (CROs)
- Diagnostic Companies
- Others
- Regional Insights (Revenue, USD Bn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- CRISPR Therapeutics
- Editas Medicine
- Intellia Therapeutics
- Merck KGaA
- Thermo Fisher Scientific
- Agilent Technologies
- Horizon Discovery
- Sangamo Therapeutics
- Cellectis
- Genomatix
- Integrated DNA Technologies
- New England Biolabs
- Takara Bio
- Bio-Rad Laboratories
- Ginkgo Bioworks
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Gene Editing Market, By Product
- Global Gene Editing Market, By Technology
- Global Gene Editing Market, By Application
- Global Gene Editing Market, By End User
- Global Gene Editing Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Gene Editing Market, By Product, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Gene Editing Market, By Technology, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Transcription Activator-Like Effector Nuclease (TALEN)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- ZFN (Zinc Finger Nucleases)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Meganucleases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Prime Editing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (PiggyBac, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Gene Editing Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Cell Line Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Genetic Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Drug Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Clinical Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Xenotransplantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Agriculture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Gene Editing Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostic Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Gene Editing Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- CRISPR Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Editas Medicine
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Intellia Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Horizon Discovery
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sangamo Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cellectis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Genomatix
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Integrated DNA Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- New England Biolabs
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takara Bio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ginkgo Bioworks
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
